Rabeprazole Sodium Market to reach USD 896.01 Mn by 2029, emerging at a CAGR of 4.6% percent and forecast 2023-2029
Rabeprazole sodium is a proton pump inhibitor (PPI) that is used to treat GERD, ulcers, and other digestive diseases. It decreases acid production by inhibiting the function of the proton …
Rabeprazole Sodium Market to reach USD 896.01 Mn by 2029, emerging at a CAGR of 4.6% percent and forecast 2023-2029 Read More